Matthew Greenig is a PhD student at the Department of Chemistry, University of Cambridge, where his research explores deep learning approaches for antibody design and optimisation. His work aims to combine large structural datasets with state of the art machine learning systems to improve and expedite the development of novel therapeutics and diagnostics. Matt’s prior work as a bioinformatician and epidemiologist has led to numerous peer-reviewed publications in respected journals.